CATALOGO DEI PRODOTTI DELLA RICERCA

LAWLOR, Rita Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.343
NA - Nord America 6.803
AS - Asia 5.959
SA - Sud America 1.094
AF - Africa 223
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 4
Totale 22.474
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.599
RU - Federazione Russa 3.065
SG - Singapore 2.228
CN - Cina 1.886
GB - Regno Unito 1.401
IT - Italia 1.291
BR - Brasile 927
HK - Hong Kong 745
DE - Germania 569
IE - Irlanda 461
SE - Svezia 413
VN - Vietnam 404
FR - Francia 376
FI - Finlandia 230
KR - Corea 174
NL - Olanda 129
CA - Canada 101
IN - India 98
AT - Austria 74
UA - Ucraina 70
MX - Messico 68
JP - Giappone 66
ES - Italia 58
ID - Indonesia 58
AR - Argentina 56
TG - Togo 50
PL - Polonia 46
TR - Turchia 45
ZA - Sudafrica 45
AU - Australia 41
BD - Bangladesh 40
BE - Belgio 40
JO - Giordania 39
BJ - Benin 31
EC - Ecuador 29
CO - Colombia 23
IR - Iran 23
MA - Marocco 23
IQ - Iraq 21
LT - Lituania 20
PK - Pakistan 19
VE - Venezuela 16
CL - Cile 15
CZ - Repubblica Ceca 15
UZ - Uzbekistan 15
BF - Burkina Faso 14
PY - Paraguay 14
SA - Arabia Saudita 14
KE - Kenya 13
KG - Kirghizistan 11
BG - Bulgaria 9
CH - Svizzera 9
EG - Egitto 9
NG - Nigeria 9
AZ - Azerbaigian 8
IL - Israele 8
MY - Malesia 8
TN - Tunisia 8
NP - Nepal 7
AE - Emirati Arabi Uniti 6
DO - Repubblica Dominicana 6
LV - Lettonia 6
PA - Panama 6
PH - Filippine 6
PT - Portogallo 6
TW - Taiwan 6
AM - Armenia 5
ET - Etiopia 5
GR - Grecia 5
NZ - Nuova Zelanda 5
PE - Perù 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
AL - Albania 4
BO - Bolivia 4
CR - Costa Rica 4
HN - Honduras 4
LU - Lussemburgo 4
MD - Moldavia 4
RO - Romania 4
UG - Uganda 4
AD - Andorra 3
DZ - Algeria 3
HR - Croazia 3
HU - Ungheria 3
IS - Islanda 3
KZ - Kazakistan 3
MK - Macedonia 3
NI - Nicaragua 3
NO - Norvegia 3
PS - Palestinian Territory 3
SV - El Salvador 3
TH - Thailandia 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
BZ - Belize 2
CI - Costa d'Avorio 2
CY - Cipro 2
EE - Estonia 2
Totale 22.446
Salva come PNG Salva come JPEG
Città #
Southend 1.154
Moscow 1.091
Dallas 1.009
Chandler 945
Singapore 918
Hong Kong 733
Verona 590
Ashburn 554
Dublin 427
Beijing 410
New York 265
Jacksonville 246
Ann Arbor 213
Woodbridge 182
Munich 174
Los Angeles 150
Lawrence 134
Princeton 134
Wilmington 130
Jinan 123
The Dalles 118
Houston 108
Ho Chi Minh City 101
Redondo Beach 99
Nanjing 93
Shenyang 88
Redmond 87
São Paulo 86
Santa Clara 84
Dong Ket 82
Columbus 81
Helsinki 78
Buffalo 77
Sindelfingen 66
Hebei 65
Nuremberg 61
Hanoi 60
Zhengzhou 59
London 58
Seattle 54
Lomé 50
Turku 50
Tokyo 49
Milan 45
Tianjin 43
Vienna 42
Brussels 40
Haikou 40
Amman 39
Changsha 39
Jakarta 39
Lappeenranta 39
Guangzhou 38
Ningbo 38
Hangzhou 37
Nanchang 36
Taizhou 34
Warsaw 34
Brooklyn 33
Council Bluffs 33
Stockholm 33
Jiaxing 32
Poplar 32
Washington 32
Cotonou 31
Seoul 31
Frankfurt am Main 30
Redwood City 30
Taiyuan 30
Brescia 29
Falkenstein 29
Rio de Janeiro 29
Johannesburg 28
Amsterdam 27
Dearborn 27
Mexico City 27
Bologna 26
Chicago 26
Madrid 26
Toronto 26
Belo Horizonte 25
Denver 25
Montreal 24
Phoenix 24
Curitiba 23
San Francisco 23
Boardman 22
Chennai 21
Kent 21
Orem 21
Shanghai 21
Manchester 20
Atlanta 19
Boston 17
Ankara 16
Brasília 16
Chions 16
Lancaster 16
Sydney 16
Fairfield 15
Totale 12.967
Salva come PNG Salva come JPEG
Nome #
Common Minimum Technical Standards and Protocols for Biobanks Dedicated to Cancer Research 486
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 244
Whole-genome landscape of pancreatic neuroendocrine tumours 244
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 226
1177PUndiscovered immune heterogeneity in pancreatic adenocarcinoma (PDAC) 222
Genomic characterization of hepatoid tumors: context matters 217
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 212
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 207
Genomic analyses identify molecular subtypes of pancreatic cancer 203
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. 202
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 199
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 193
Gα15 in early onset of pancreatic ductal adenocarcinoma 192
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 187
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 182
RON is not a prognostic marker for resectable pancreatic cancer 176
428OImmune landscape of pancreatic neuroendocrine tumours (PanNETs) 174
A multimodality test to guide the management of patients with a pancreatic cyst 170
Reporting tumor molecular heterogeneity in histopathological diagnosis 169
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients 167
CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas 167
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 165
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 164
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 162
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 161
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer 161
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 160
A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk 159
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 158
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 156
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 156
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 154
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation 154
Lost in translation: returning germline genetic results in genome-scale cancer research 153
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 152
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 152
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 151
Ampulla of Vater carcinoma: Molecular landscape and clinical implications 151
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 150
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 148
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer 148
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 148
Hypermutation In Pancreatic Cancer 147
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 147
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 146
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 146
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer 146
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms 144
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 144
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 144
Comparative Lesions Analysis Through a Targeted Sequencing Approach 142
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study 142
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 141
Splice variants as novel targets in pancreatic ductal adenocarcinoma 139
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation 139
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 139
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 139
Exosomal miRNA signatures of pancreatic lesions 137
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 136
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 134
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 133
Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma 132
International network of cancer genome projects 131
Research capacity. Enabling the genomic revolution in Africa 131
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 130
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan 130
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients 130
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 129
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 129
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 129
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 129
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 128
Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium 128
Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids 126
Loss of FGFR4 promotes the malignant phenotype of PDAC 125
Biosampling and biobanking (Chapter7) 123
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 123
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 122
Whole genomes redefine the mutational landscape of pancreatic cancer 121
A Model of Collaboration ad Experiences between Bio-industry and Academic Biobanks 121
Sex differences in oncogenic mutational processes 121
Genome-wide association study identifies an early onset pancreatic cancer risk locus 120
Divergent mutational processes distinguish hypoxic and normoxic tumours 119
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 119
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns 118
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes 118
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis 118
Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary 117
Urine Metabolic Signature of Pancreatic Ductal Adenocarcinoma by (1)H Nuclear Magnetic Resonance: Identification, Mapping, and Evolution 117
Author Correction: The landscape of viral associations in human cancers 116
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 116
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 116
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 116
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 116
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 115
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations 115
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 115
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling 114
The Global Genome Biodiversity Network (GGBN) Data Standard specification 113
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 112
Totale 15.135
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.043
article - articoli 78.634
book - libri 1.034
conference - conferenze 1.138
curatela - curatele 0
other - altro 971
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.266
Totale 166.086
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021639 0 0 0 0 140 110 35 24 43 45 90 152
2021/20221.318 127 354 75 114 52 33 54 90 51 32 81 255
2022/20232.624 160 320 203 439 219 619 45 165 291 35 89 39
2023/20241.877 57 124 125 168 177 330 95 192 56 129 305 119
2024/20255.563 298 285 329 815 309 299 429 340 704 346 522 887
2025/20267.643 1.058 735 1.147 2.330 2.373 0 0 0 0 0 0 0
Totale 22.960